Durvalumab-based Treatment Before and After Surgery Improved Outcomes for Patients With Resectable Non-small Cell Lung Cancer
Patients treated with the durvalumab-based regimen before and after surgery in the AEGEAN trial had a 32% reduction in...
Patients treated with the durvalumab-based regimen before and after surgery in the AEGEAN trial had a 32% reduction in...
SAN ANTONIO – Residual tumors from Black patients with estrogen receptor (ER)-positive/HER2-negative primary breast cancer treated with neoadjuvant chemotherapy...
SAN ANTONIO – Women 50 or older who de-escalated to less-frequent mammography three years after curative surgery for early-stage...
Imaging mass cytometry was feasible in a large clinical trial of atezolizumab in combination with chemotherapy SAN ANTONIO –...
The ESMO Scale for Clinical Actionability of molecular Targets (ESCAT) was highly predictive of the benefits of targeted therapies...
PHILADELPHIA, PA and CAMBRIDGE, MA – January 19, 2021 — Three grants for research that could transform cancer therapies...
Disaggregating statistics revealed key differences in ethnic populations ORLANDO, Fla. – An analysis of lung cancer incidence rates showed...
Researchers caution that disparities may worsen as the recommended screening age is lowered PHILADELPHIA – In 2018, Americans aged...
PHILADELPHIA – The American Association for Cancer Research (AACR) will award Carl H. June, MD, Fellow of the AACR...
SAN ANTONIO – Jeffrey M. Rosen, PhD, will receive the William L. McGuire Memorial Lecture Award at the 2022...
ORLANDO, Fla. – A combination of the PARP inhibitor olaparib (Lynparza) and the investigational ATR inhibitor ceralasertib showed clinical...
PHILADELPHIA – Lower levels of cancer aneuploidy were associated with more favorable outcomes after immune checkpoint inhibition in patients...
Outcomes were similar between Black patients and patients of other races PHILADELPHIA – Treatment outcomes were similar between Black...
sFRP2, but not VEGF, may promote angiogenesis in older patients with melanoma PHILADELPHIA – Younger patients with resected melanoma...
“SAN ANTONIO – Patients with early-stage breast cancer who had cancer detected in a sentinel lymph node biopsy had...
PHILADELPHIA: – In patients with soft tissue sarcoma, the concomitant use of gastric acid suppressant (GAS) therapy and the...
PHILADELPHIA – The histone deacetylase (HDAC) inhibitor vorinostat (Zolinza) in combination with the mTOR inhibitor sirolimus (Rapamune) or everolimus...
Study reports progressive improvement in the outcomes of patients carrying the Philadelphia chromosome PHILADELPHIA – For patients with acute...
Dr. Antoni Ribas Inaugurated as President PHILADELPHIA — The American Association for Cancer Research (AACR) welcomes Antoni Ribas, MD,...
PHILADELPHIA – The American Association for Cancer Research (AACR) today announced the formation of its eighth and newest scientific...
Five new members elected to the Board of Directors PHILADELPHIA – The members of the American Association for Cancer...
Five new members elected to the Board of Directors and four new members elected to the Nominating Committee PHILADELPHIA...
10 members of the AACR elected, including Fellow of the AACR Academy Drew Pardoll, MD, PhD PHILADELPHIA – The...
Cash Prize of $5,000 in Each of the Six Categories PHILADELPHIA – The submission deadline for the American Association...
PHILADELPHIA – The American Association for Cancer Research (AACR) Foundation today announced a fundraising partnership with The Battle Cancer...
PHILADELPHIA — The American Association for Cancer Research (AACR) today announced the opening of the submission site for its...
The American Association for Cancer Research and the St. Baldrick’s Foundation are pleased to announce the creation of the AACR-St....
Letters of Intent to participate in the program and related workshop due May 28 PHILADELPHIA – Today, the American...
Researchers partnered with Gift of Life Michigan to analyze healthy pancreata from deceased donors PHILADELPHIA – Pancreatic intraepithelial neoplasia...
PHILADELPHIA — T cells targeting p53 hotspot mutations can be harvested from peripheral blood of patients with metastatic solid epithelial cancers, according to...